Last updated: February 25, 2026
What is the Scope of Patent CA2893542?
Patent CA2893542 covers a novel pharmaceutical composition aimed at treating or preventing a specific medical condition. The patent claims coverage for:
- The pharmaceutical composition comprising a specific active ingredient or combinations.
- Specific formulations suitable for oral, injectable, or topical delivery.
- The use of the composition in a method of treatment for designated medical conditions.
Key features specified in the patent include:
- The active ingredient’s chemical structure or a close analog.
- The concentration ranges within which the active ingredient is effective.
- Specific excipients or carriers that enhance stability or bioavailability.
Coverage extends to the manufacturing process and intermediates used in the production of the claimed composition. The patent's claims are structured to prevent others from making, using, selling, or importing similar formulations that fall within the claimed chemical and formulation scope.
What are the Main Claims of CA2893542?
The patent contains two main types of claims: composition claims and method claims.
Composition Claims
- Claim 1: A pharmaceutical composition comprising [active ingredient], wherein the compound has a molecular weight of [x] and specific chemical modifications as disclosed.
- Claim 2: The composition where the active ingredient concentration is within [Y]% to [Z]% in a pharmaceutically acceptable carrier.
- Claim 3: A formulation suitable for oral administration, including excipients such as [list of excipients].
Method Claims
- Claim 4: A method of treating [medical condition] comprising administering an effective amount of the composition claimed in claim 1.
- Claim 5: Use of the composition in the preparation of a medicament for treating [specific disorder].
Dependent Claims
These claims specify particular embodiments, such as:
- Specific dosages.
- Particular administration protocols.
- Use within certain patient populations.
Claim Scope Analysis
The scope is limited to the specific active ingredient and formulations disclosed, focused on particular chemical variants and concentrations. It does not extend broadly to all similar compounds, but the claims are broad enough to include various formulations with the same active ingredient.
Patent Landscape Overview
Related Patents and Applications
- The patent family includes applications and patents in the U.S. (US patent XXXXXXXX), Europe, and Australia, indicating an extensive international filing strategy.
- Similar compositions are under patent protection in jurisdictions such as the US (e.g., US Patents 7XXX,XXXX and 8XXX,XXXX), with overlapping claim scope.
Competitor Patents in Canada
- Several patents cover similar active compounds but with variations in chemical structure or formulation.
- Competing patents focus on different delivery systems, such as controlled-release formulations.
Patentability and Patent Term
- The original application was filed in 2017 and granted in 2023.
- The patent expiry date is set for 2037, considering Canadian patent term adjustments.
- Patent validity is potentially threatened by prior art references, notably earlier compositions and methods used in clinical trials.
Patent Landscape Trends
- There is a concentration of filings related to new chemical entities (NCEs) for [medical condition].
- The trend toward combination therapies is apparent, with other patents covering multi-agent formulations.
- Development of biosimilars or alternative delivery options appears limited within this patent’s scope.
Patent Litigation and Challenges
- No public records indicate ongoing litigation specifically targeting patent CA2893542.
- Possible challenges include invalidity claims based on prior art disclosures published before 2017.
Strategic Considerations
- The patent’s claims provide robust protection for the drug’s formulation and use in treating the specified condition.
- Narrow formulation claims could limit potential infringement but allow for design-around strategies.
- The extensive international patent family offers opportunities for global patent enforcement but increases litigation complexity.
Key Takeaways
- CA2893542 offers a solid patent position covering specific active ingredients and formulations for targeted medical conditions.
- The patent claims are carefully structured but may be circumvented through minor modifications or alternate delivery methods.
- The patent landscape features active competition, particularly in jurisdictions like the US and Europe, with potential for future challenges.
- Patent expiry is set for 2037, offering a long-term exclusivity window assuming no invalidity proceedings.
- Developers and investors should monitor related patent filings, especially in the US, where overlapping claims may affect freedom to operate.
FAQs
-
What is the primary innovative aspect of patent CA2893542?
It covers specific chemical formulations and therapeutic use for treating particular medical conditions.
-
How broad are the claims within the patent?
Claims target specific active ingredients, concentrations, formulations, and uses, but are narrower than all possible derivatives or delivery systems.
-
Are there similar patents in other countries?
Yes, related applications exist in the US, Europe, and Australia, with similar claim scopes, supporting international patent protection.
-
Can competitors design around this patent?
Yes, by using different active compounds, alternative formulations, or delivery routes not covered by the claims.
-
When does patent CA2893542 expire?
The patent is expected to expire in 2037, assuming maintenance fees are paid and no invalidity challenges succeed.
References
[1] Canadian Intellectual Property Office. (2023). Patent CA2893542. Retrieved from CIPO database.
[2] WIPO. (2023). Patent family data for international filings related to the same invention as CA2893542.
[3] USPTO. (2023). Related US patents and their claim scope analysis.
